However, loss of claudin-1 expression is a strong predictor of disease recurrence and poor patient survival in stage II CRC [177], while a decrease in claudin-4 at the invasive front in CRC has been associated with cancer invasion and metastasis [178]. This evidence concerns the gene CLDN1 and colorectal carcinoma.